drugset / Trial / NCT06860750

A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

NCT06860750

Phase 3 Recruiting 380 enrolled Suzhou Suncadia Biopharmaceuticals Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy and safety of SHR-1314 injection in adult patients with active non-radiographic axial spondyloarthritis.

Timeline

Start
2025-04-29
Primary completion
2028-02
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject vunakizumab Protein / enzyme biologic

Indications